Nathan Connell Speaks on Gender Diversity In Haemostasis Care at EAHAD 2026
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared a post on LinkedIn:
”Honored to speak at EAHAD 2026 in Dublin
Grateful to the European Association for Haemophilia and Allied Disorders (EAHAD) — and especially the Women and Girls+ with Bleeding Disorders Working Group — for the invitation to present on: ‘Gender diversity in haemostasis care: bridging gaps in an evolving landscape.’
This session was an opportunity to step back and reflect on how sex, gender, identity, and lived experience intersect with bleeding and thrombotic disorders — and how our field can continue moving toward more inclusive, evidence-informed, and patient-centered care.
Some key themes from my presentation:
- Harm reduction as a shared goal across all perspectives — fewer clots, fewer bleeds, better lives
- The importance of language, respectful communication, and creating affirming clinical environments
- Intersectionality and the mental health burden faced by many patients with bleeding disorders and gender diversity
- Individualized, shared decision-making in areas like hormone therapy, surgery, and anticoagulation — especially where evidence is evolving
I’m incredibly appreciative of the thoughtful dialogue and followup from colleagues and the opportunity to learn from such a multidisciplinary and international community committed to advancing hemostasis care.
Thank you again to Niamh O’Connell, Jan Blatný, Michelle Lavin, the entire Congress organizing committee, and to everyone who engaged in this important conversation.”

Stay updated with Hemostasis Today.
-
Jul 9, 2026, 14:38Valance Washington: International Hemostasis Community Prepares for GRC 2026
-
Jul 9, 2026, 14:27Dima Shulkin: Next-Generation AI Models Improve Early Sepsis Recognition
-
Jul 9, 2026, 14:12Omar Hajji: Seasonal Determinants of Mortality in Sepsis and Cardiogenic Shock
-
Jul 9, 2026, 13:54Hussein Yassine: Why Omega-3s May Fall Short in Preventing Alzheimer’s Disease
-
Jul 9, 2026, 13:16Olivier Mathieu: Innovating the Future of Hemostasis at ISTH 2026
-
Jul 9, 2026, 12:41Thomas Palmer-Dench: Hexokinase Controls Platelet Activation and Hemostasis
-
Jul 9, 2026, 12:19Paschalis Evangelidis: Join Our Special Issue on Thrombosis and Vascular Disorders
-
Jul 9, 2026, 12:16Fernanda Betti Solano: Could Iron Deficiency Be Affecting Your Sleep?
-
Jul 9, 2026, 12:08Andreas Calatzis: What is the Rationale for Collagen-Induced Platelet Aggregation Testing?